Battle Over Deferred Drug Listings In Australia: Should Cost-Effective Drugs Always Be Funded?
This article was originally published in PharmAsia News
Executive Summary
A storm is brewing in the lead up to Australia's May 10 federal budget over the nation's Pharmaceutical Benefits Scheme, which acts as a single payer to subsidize drug prices and is administered by the government